43568
39555
S&P/TSX
15183.13
-81.51
-0.53%
S&P-CDNX
760.88
-3.65
-0.48%
S&P-500
2472.54
-0.91
-0.04%
NASDAQ
6387.7539
-2.2480
-0.0352%
Dow
21580.07
-31.71
(-0.15%)
Dollar
0.7977
+0.0036
+0.4533%
Oil
46.73
-0.39
-0.83%
Gold
1251.10
+6.30
+0.51%
Silver
16.375
+0.076
+0.466%


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

43335
Recent Trending
Castanet Proud Member of RTNDA Canada
41739
Press Room